
Stephen Sanders
Examiner (ID: 19298, Phone: (571)270-5308 , Office: P/2434 )
| Most Active Art Unit | 2434 |
| Art Unit(s) | 2434, 2439 |
| Total Applications | 325 |
| Issued Applications | 261 |
| Pending Applications | 0 |
| Abandoned Applications | 65 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8916354
[patent_doc_number] => 20130177979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'METHODS AND COMPOSITIONS FOR CELL PERMEABLE STAT3 INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 13/806639
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 31313
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13806639
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/806639 | METHODS AND COMPOSITIONS FOR CELL PERMEABLE STAT3 INHIBITOR | Jun 21, 2011 | Abandoned |
Array
(
[id] => 8964063
[patent_doc_number] => 20130203665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'SINGLE-CHAIN INSULIN AGONISTS EXHIBITING HIGH ACTIVITY AT THE INSULIN RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 13/701146
[patent_app_country] => US
[patent_app_date] => 2011-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 72905
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701146
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/701146 | Single-chain insulin agonists exhibiting high activity at the insulin receptor | Jun 15, 2011 | Issued |
Array
(
[id] => 9162027
[patent_doc_number] => 20130310304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/704477
[patent_app_country] => US
[patent_app_date] => 2011-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10626
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704477
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/704477 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATHEROSCLEROSIS | Jun 14, 2011 | Abandoned |
Array
(
[id] => 11799839
[patent_doc_number] => 09540634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Transcriptome in vivo analysis'
[patent_app_type] => utility
[patent_app_number] => 13/702415
[patent_app_country] => US
[patent_app_date] => 2011-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12717
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13702415
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/702415 | Transcriptome in vivo analysis | Jun 6, 2011 | Issued |
Array
(
[id] => 8733716
[patent_doc_number] => 20130079285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'SOLUBILIZED COLLAGEN FIBERS AND METHOD FOR PRODUCING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/700623
[patent_app_country] => US
[patent_app_date] => 2011-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16313
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700623
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/700623 | SOLUBILIZED COLLAGEN FIBERS AND METHOD FOR PRODUCING THE SAME | May 29, 2011 | Abandoned |
Array
(
[id] => 9401719
[patent_doc_number] => 08691771
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-08
[patent_title] => 'Bi-specific fusion proteins for tissue repair'
[patent_app_type] => utility
[patent_app_number] => 13/112907
[patent_app_country] => US
[patent_app_date] => 2011-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14807
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112907
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/112907 | Bi-specific fusion proteins for tissue repair | May 19, 2011 | Issued |
Array
(
[id] => 8854128
[patent_doc_number] => 20130143803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-06
[patent_title] => 'Process for the Preparation of Insulin-Zinc Complexes'
[patent_app_type] => utility
[patent_app_number] => 13/696897
[patent_app_country] => US
[patent_app_date] => 2011-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8654
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696897
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/696897 | Process for the Preparation of Insulin-Zinc Complexes | May 8, 2011 | Abandoned |
Array
(
[id] => 9034847
[patent_doc_number] => 20130237485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-12
[patent_title] => 'Methods and Agents for Enhancing Wound Healing'
[patent_app_type] => utility
[patent_app_number] => 13/696587
[patent_app_country] => US
[patent_app_date] => 2011-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3789
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696587
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/696587 | Methods and Agents for Enhancing Wound Healing | May 5, 2011 | Abandoned |
Array
(
[id] => 8745543
[patent_doc_number] => 20130085260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'METHOD FOR THE IDENTIFICATION OF T CELL EPITOPES'
[patent_app_type] => utility
[patent_app_number] => 13/642685
[patent_app_country] => US
[patent_app_date] => 2011-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8730
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642685
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/642685 | METHOD FOR THE IDENTIFICATION OF T CELL EPITOPES | Apr 20, 2011 | Abandoned |
Array
(
[id] => 8697791
[patent_doc_number] => 20130059800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'PYRROLOBENZODIAZEPINES USED TO TREAT PROLIFERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/641180
[patent_app_country] => US
[patent_app_date] => 2011-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 31658
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641180
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641180 | Pyrrolobenzodiazepines used to treat proliferative diseases | Apr 14, 2011 | Issued |
Array
(
[id] => 8637114
[patent_doc_number] => 20130028917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/641198
[patent_app_country] => US
[patent_app_date] => 2011-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 69309
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641198
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641198 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | Apr 14, 2011 | Abandoned |
Array
(
[id] => 8489056
[patent_doc_number] => 20120288463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'COSMETIC BASE MATERIAL AND COSMETIC CONTAINING THIS COSMETIC BASE MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 13/521529
[patent_app_country] => US
[patent_app_date] => 2011-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16988
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13521529
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/521529 | COSMETIC BASE MATERIAL AND COSMETIC CONTAINING THIS COSMETIC BASE MATERIAL | Apr 11, 2011 | Abandoned |
Array
(
[id] => 8065055
[patent_doc_number] => 20110244498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'TYROSINE KINASE-INDUCIBLE DOMAINS'
[patent_app_type] => utility
[patent_app_number] => 13/078494
[patent_app_country] => US
[patent_app_date] => 2011-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11031
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0244/20110244498.pdf
[firstpage_image] =>[orig_patent_app_number] => 13078494
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/078494 | Tyrosine kinase-inducible domains | Mar 31, 2011 | Issued |
Array
(
[id] => 8829941
[patent_doc_number] => 20130130986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'CANCER TREATMENT WITH RECOMBINANT VECTOR'
[patent_app_type] => utility
[patent_app_number] => 13/638490
[patent_app_country] => US
[patent_app_date] => 2011-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22773
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638490
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/638490 | CANCER TREATMENT WITH RECOMBINANT VECTOR | Mar 28, 2011 | Abandoned |
Array
(
[id] => 8977321
[patent_doc_number] => 20130210751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands'
[patent_app_type] => utility
[patent_app_number] => 13/634631
[patent_app_country] => US
[patent_app_date] => 2011-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6755
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13634631
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/634631 | Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands | Mar 13, 2011 | Abandoned |
Array
(
[id] => 9003107
[patent_doc_number] => 20130224232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'CYCLIC TETRAPEPTIDES AND THERAPEUTIC APPLICATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/579933
[patent_app_country] => US
[patent_app_date] => 2011-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16722
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579933
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/579933 | CYCLIC TETRAPEPTIDES AND THERAPEUTIC APPLICATIONS THEREOF | Feb 18, 2011 | Abandoned |
Array
(
[id] => 6142123
[patent_doc_number] => 20110129448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'METHODS TO MOBILIZE PROGENITOR/STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/023381
[patent_app_country] => US
[patent_app_date] => 2011-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12407
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129448.pdf
[firstpage_image] =>[orig_patent_app_number] => 13023381
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/023381 | METHODS TO MOBILIZE PROGENITOR/STEM CELLS | Feb 7, 2011 | Abandoned |
Array
(
[id] => 7696163
[patent_doc_number] => 20110230427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'MATERIALS AND METHODS FOR STABILIZING NANOPARTICLES IN SALT SOLUTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/005250
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8100
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230427.pdf
[firstpage_image] =>[orig_patent_app_number] => 13005250
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/005250 | Materials and methods for stabilizing nanoparticles in salt solutions | Jan 11, 2011 | Issued |
Array
(
[id] => 6110431
[patent_doc_number] => 20110189284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'Peptide Fibres'
[patent_app_type] => utility
[patent_app_number] => 12/974561
[patent_app_country] => US
[patent_app_date] => 2010-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11976
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20110189284.pdf
[firstpage_image] =>[orig_patent_app_number] => 12974561
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/974561 | Peptide Fibres | Dec 20, 2010 | Abandoned |
Array
(
[id] => 9676893
[patent_doc_number] => 08815802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-26
[patent_title] => 'GLP-1 analogues and derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/516312
[patent_app_country] => US
[patent_app_date] => 2010-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40679
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516312
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/516312 | GLP-1 analogues and derivatives | Dec 15, 2010 | Issued |